Evidence map›Paper›PMID 28570130›Full record

ArticleJournal of computational biology : a journal of computational molecular cell biology2017

An Integrative Computational Approach to Evaluate Genetic Markers for Chronic Lymphocytic Leukemia.

Yu Zheng, Xiaoyang Li, Lydia C Manor, Hongbao Cao, Qiusheng Chen

Abstract read
In one paragraph

Article in Journal of computational biology : a journal of computational molecular cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu Zheng1 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University , School of Medicine, Shanghai, China .
Xiaoyang Li1 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University , School of Medicine, Shanghai, China .
Lydia C Manor2 Department of Bioinformatics Service, American Informatics Consultant LLC , Rockville, Maryland.
Hongbao Cao3 Department of Genomics Research, R&D Solutions, Elsevier Inc. , Rockville, Maryland.
Qiusheng Chen1 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University , School of Medicine, Shanghai, China .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies reported hundreds of genes linked to chronic lymphocytic leukemia (CLL). However, many of these candidate genes were lack of replication and results were not always consistent. Here, we proposed a computational workflow to curate and evaluate CLL-related genes. The method integrates large-scale literature knowledge data, gene expression data, and related pathways/network information for quantitative marker evaluation. Pathway Enrichment, Sub-Network Enrichment, and Gene-Gene Interaction analysis were conducted to study the pathogenic profile of the candidate genes, with four metrics proposed and validated for each gene. By using our approach, a scalable CLL genetic database was developed including CLL-related genes, pathways, diseases and information of supporting references. The CLL case/control classification supported the effectiveness of the four proposed metrics, which successfully identified nine well-studied CLL genes (i.e., TNF, BCL2, TP53, VEGFA, P2RX7, AKT1, SYK, IL4, and MDM2) and highlighted two newly reported CLL genes (i.e., PDGFRA and CSF1R). The computational biology approach and the CLL database developed in this study provide a valuable resource that may facilitate the understanding of the genetic profile of CLL.

Indexed as

SoftwareBiomarkers, TumorEvaluation Studies as TopicGene Regulatory NetworksHumansLeukemia, LymphoidBiomarkers, Tumorchronic lymphocytic leukemiagenetic network analysisliterature data miningpathway enrichment analysissub-network enrichment analysis

Identifiers

PMID28570130
PMCPMC11753456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.